Child Health Institute of New Jersey

What Child Health Institute of New Jersey does

The Child Health Institute of New Jersey (CHINJ) is a non-profit academic research institute operating within Rutgers, The State University of New Jersey, located at 89 French Street, New Brunswick, NJ. Founded in the late 1990s with founding support from the Robert Wood Johnson Foundation and Johnson & Johnson, CHINJ occupies a 40,000-square-foot research building completed in September 2005 and is led by Director Arnold B. Rabson, MD. The institute organizes its work around four major research programs: inflammation/immune/infectious diseases, neurodevelopment/autism, pediatric cancers/stem cells, and childhood obesity/metabolism.

CHINJ's core technology stack is built around advanced shared research resources rather than commercial products. Capabilities include cellular imaging (multiple Zeiss, Bruker, Leica, and Keyence confocal and multiphoton systems), single-cell analysis (Cytek Aurora spectral flow cytometers, BD LSR II, Cytek Aurora CS cell sorter, 10X Genomics Chromium Controller), human neuron functional analysis (Pang lab), neurobehavioral analysis (Manzini lab), a Genome Editing Shared Resource for mouse model generation, and an Aquatic Core for zebrafish-based disease modeling and drug screening. CHINJ is a co-owner of the SMILEY© pediatric lupus quality-of-life instrument, adapted in more than 30 countries.

CHINJ is not a commercial enterprise and has no pricing model. Revenue is a combination of federal research grants (predominantly NIH R01/U01/R34 and BRAIN Initiative awards, including a cited $1.6M COVID-19 study), foundation grants (Robert Wood Johnson Foundation for J3PS and NJHKI; Hudson Shea Foundation for premature infant research), Rutgers institutional support, and individual donations routed through the Friends of CHINJ mailing list. Its "customers" are research scientists, postdoctoral and graduate trainees, clinical partners at Bristol-Myers Squibb Children's Hospital, PSE&G Children's Specialized Hospital, Rutgers Cancer Institute of New Jersey, and the Pediatric Clinical Research Center, plus donor constituents. Distribution of research outputs occurs through scientific publications, clinical translation pipelines via NJ ACTS, and integration with Robert Wood Johnson Medical School pediatric training programs.

Name

Child Health Institute of New Jersey

Legal name

Child Health Institute of New Jersey

Website

https://childhealthinstitute.rutgers.edu

Company type

Private

Founded year

1990

Operating status

Operating

Headcount range

11–50 employees

Short description

Child Health Institute of New Jersey (CHINJ) is a non-profit pediatric research institute within Rutgers University that investigates childhood diseases across four programs — inflammation, neurodevelopment/autism, pediatric cancers, and obesity — and trains postdoctoral, graduate, and medical researchers.

Ownership category

akta.pro rank

Product category

Pediatric Biomedical Research

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Pediatrics & Adolescent Medicine Practices (HLAFAJAF)

akta.pro secondary industry

Schools of Public Health (EDAHAGAD)

Keywords

• Pediatric medical research
• Child health research
• Translational biomedical research
• Pediatric cancer research
• Academic research institute

Headquarters

HQ city

New Brunswick

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Others

Revenue model

1. Foundation and Corporate Funding: CHINJ was founded in the late 1990s with generous support from Robert Wood Johnson Foundation and Johnson & Johnson. Ongoing foundation support includes grants from Robert Wood Johnson Foundation for Joint Program in Population and Prevention Sciences (J3PS) and New Jersey Healthy Kids Initiative.
2. Federal Research Grants: NIH grant support including R01 grants, U01 grants, R34 grants, and BRAIN Initiative grants. National Institutes of Health awarded $1.6 million for COVID-19 study. Continuous NIH grant support since 2004 for some researchers.
3. Donations and Charitable Contributions: Donations from public through website. Partnership with Hudson Shea Foundation provided $100,000 for research on preventing diseases of premature infants with $100,000 pledged for next five years.
4. Clinical Research Services: Scientists utilize clinical research cores of NJ ACTS to translate laboratory discoveries into clinical practice. Revenue from clinical research activities.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

CHINJ is a non-profit academic research institute that investigates the causes of childhood illnesses — including asthma, diabetes, autism, neuropsychiatric disorders, cancer, inflammatory bowel disease, and obesity — and translates laboratory discoveries into new pediatric treatments and preventions. The institute operates four major research programs (inflammation/immune/infectious diseases, neurodevelopment/autism, pediatric cancers/stem cells, and childhood obesity/metabolism) and provides postdoctoral, graduate, medical-student, and undergraduate research training alongside shared research instrumentation.

Product overview

The Child Health Institute of New Jersey (CHINJ) is a research institute affiliated with Rutgers Robert Wood Johnson Medical School. It is not a product company; it does not offer commercial software products, platforms, or SaaS services. CHINJ conducts basic, translational, and population-based research in child health areas including inflammatory diseases, neurodevelopment and autism, pediatric cancers, and childhood obesity. The institute provides research training for postdoctoral fellows, graduate students, medical students, and undergraduates, and maintains shared research resources for its investigators.

Differentiator

Problem solved

Functional benefit

Products and services

• Inflammation, Immune and Infectious Diseases Research Program One of CHINJ's four major research programs focused on understanding immune mechanisms and infectious disease processes that affect children, including identification of intestinal immune cells relevant to inflammatory bowel disease and Crohn's disease.
• Neurodevelopment and Autism Research Program One of CHINJ's four major research programs focused on genetic and developmental mechanisms underlying autism spectrum disorder, neuropsychiatric disorders, and brain development, including prenatal origins of autism and gene-mutation effects on brain cells.
• Pediatric Cancers and Stem Cells Research Program One of CHINJ's four major research programs focused on molecular pathogenesis of pediatric cancers and stem-cell biology, conducted in collaboration with the Rutgers Cancer Institute of New Jersey, the only NCI-designated Comprehensive Cancer Center in the state.
• Childhood Obesity and Metabolism Research Program One of CHINJ's four major research programs focused on metabolic and neuro-metabolic drivers of childhood obesity, including hypothalamic circuit dysfunction in diet-induced obesity, partnered with the Rutgers Institute for Food, Nutrition and Health under the New Jersey Healthy Kids Initiative.
• CHINJ Research Education and Training Program Structured training pathway for postdoctoral fellows, graduate students (PhD, MD/PhD, Master's), medical students, and undergraduates, providing mentorship and access to CHINJ shared resources and research laboratories.
• Cellular Imaging Shared Resource Shared core facility offering advanced confocal and multiphoton microscopy, including Zeiss LSM700, LSM800, LSM980, Bruker Nanor Ultima and NeuraLight multiphoton systems, Leica DMi8 with Hamamatsu splitter, and Keyence BZ-X800E imaging platforms.
• Single Cell Analysis Shared Resource Shared core facility providing flow cytometry and single-cell genomics instrumentation, including Cytek Aurora Spectral Flow Cytometer, Cytek Aurora CS Cell Sorter, BD LSR II Flow Cytometer, and 10X Genomics Chromium Controller.
• Genome Editing Shared Resource (GESR) Core facility directed by Drs. Peter Romenienko and Ghassan Yehia that supports development and production of genetically modified mouse models of human disease, physically located at CHINJ.
• Aquatic Zebrafish Core Core resource that models human neurodevelopmental and childhood musculoskeletal disorders in zebrafish and performs rapid screening of potential novel therapeutics.
• SMILEY© (Simple Measure of Impact of Lupus Erythematosus in Youngsters) Health-related quality-of-life assessment designed for children with systemic lupus erythematosus, developed by Dr. Lakshmi Nandini Moorthy and adapted in more than thirty countries through the International SMILEY© Collaborative Group.

Quantifiable outcome

• Studies on autism spectrum disorder genetics and brain development
• +2 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Six partnerships are on record, tiered core and notable.

• Bristol-Myers Squibb Children's Hospital at Robert Wood Johnson University HospitalcoreStrategic or Co-development PartnerCHINJ integrates with world-class pediatricians at this affiliated hospital. The hospital is part of the child-focused, research and clinical care campus including RWJMS Department of Pediatrics and Pediatric Clinical Research Center.
• PSE&G Children's Specialized HospitalcoreStrategic or Co-development PartnerCHINJ partners with this specialized children's hospital as part of the integrated child health campus for translating research into clinical care.
• Robert Wood Johnson Medical SchoolcoreStrategic or Co-development PartnerCHINJ integrates with world-class pediatricians at Rutgers Robert Wood Johnson Medical School. The institute is part of the Robert Wood Johnson Medical School ecosystem.
• Rutgers Cancer Institute of New JerseycoreStrategic or Co-development PartnerOnly NCI-designated Comprehensive Cancer Center in New Jersey. Located nearby CHINJ and serves as a leading center for pediatric cancers. CHINJ scientists work with Rutgers Cancer Institute on pediatric cancer research.
• Pediatric Clinical Research CentercoreStrategic or Co-development PartnerPart of of NJ ACTS (New Jersey Alliance for Clinical and Translational Science) providing clinical research infrastructure for translating laboratory discoveries into clinical practice.
• Rutgers Institute for Food, Nutrition and HealthnotableStrategic or Co-development PartnerPartner in New Jersey Healthy Kids Initiative (NJHKI) tackling childhood obesity, funded by Robert Wood Johnson Foundation.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Stanley Manne Children's Research Institute (Ann & Robert H. Lurie Children's Hospital of Chicago): Pediatric research institute embedded within a children's hospital system, with programs in pediatric cancer, genomics, and developmental biology — a directly comparable academic pediatric research model.
• Children's National Research Institute: Pediatric research arm of Children's National Hospital, with translational programs in cancer, genetics, and immunology — comparable academic-medical pediatric research model.
• Cincinnati Children's Research Foundation: Top-ranked pediatric research institute affiliated with Cincinnati Children's Hospital, with deep programs in pediatric cancer, immunology, and developmental biology — comparable in scope and academic-medical structure to CHINJ.
• Seattle Children's Research Institute: Major pediatric research institute housed within a children's hospital, with strengths in immunotherapy, neuroscience, and infectious disease — directly comparable to CHINJ's four research programs.
• Nemours Children's Health Research: Pediatric research arm of the Nemours Children's Health system, with translational programs in childhood disease — comparable in pediatric translational focus.
• Children's Hospital of Philadelphia Research Institute: Largest pediatric research enterprise in the US, also university-affiliated and focused on childhood disease research spanning genomics, cancer, and neuroscience — directly comparable to CHINJ's translational pediatric mission.
• St. Jude Children's Research Hospital: Leading pediatric-focused research hospital, particularly in childhood cancer and infectious disease — closely comparable in pediatric disease specialization and translational orientation.
• Murdoch Children's Research Institute: Largest pediatric research institute in Australia, affiliated with the Royal Children's Hospital and University of Melbourne, with comparable translational pediatric research programs.
• Texas Children's Research Institute: Pediatric research enterprise of Texas Children's Hospital, with major programs in pediatric cancer, neurology, and infectious disease — directly comparable in scope and structure.

Emerging players

• Whitehead Institute for Biomedical Research: MIT-affiliated basic biomedical research institute with strong programs in developmental biology, genetics, and disease modeling — comparable in academic research institute structure but with broader (non-pediatric) research scope.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/chinjrutgers
• LinkedInlinkedin.com/company/child-health-institute-of-new-jersey

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Child Health Institute of New Jersey